FIELD: experimental pathophysiology. SUBSTANCE: 10% activated carbon suspension is administered in rats intragastrically in summary dose 2 g/kg body wt. EFFECT: enabled simulation of evacuation movement function disorder and provided method for studying mechanism of constipation and searching new purgatives. 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PURGATIVE DRUG | 1998 |
|
RU2144823C1 |
METHOD OF PREPARING SUBSTANCE SHOWING ANTIULCER ACTIVITY AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1993 |
|
RU2071343C1 |
HEMORHEOLOGICAL AGENT | 1998 |
|
RU2138285C1 |
ANTIULCER AGENT AND METHOD OF ITS PREPARING | 1998 |
|
RU2141332C1 |
HEMORHEOLOGICAL AND ANTITHROMBOTIC AGENT | 2003 |
|
RU2239423C1 |
AGENT AGAINST INFECTIONS CAUSED BY LISTERIA | 1994 |
|
RU2079302C1 |
METHOD OF PREPARING THE AGENT SHOWING ANTIULCER ACTION | 1994 |
|
RU2086251C1 |
METHOD FOR MANUFACTURING ANTIULCEROUS DRUG | 1992 |
|
RU2045957C1 |
COMPOSITION FEATURING VITAMIN ACTIVITY | 1992 |
|
RU2045273C1 |
METHOD FOR MODELLING CEREBRAL ISCHEMIA DISEASE AGGRAVATED BY HEMISPHERE ASYMMETRY PHENOMENA | 1993 |
|
RU2083000C1 |
Authors
Dates
2000-01-10—Published
1998-11-20—Filed